Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1955 1
1956 4
1957 3
1958 1
1959 1
1962 2
1963 7
1964 6
1965 8
1966 8
1967 14
1968 12
1969 21
1970 13
1971 11
1972 23
1973 16
1974 16
1975 23
1976 14
1977 17
1978 18
1979 31
1980 34
1981 41
1982 43
1983 50
1984 67
1985 83
1986 98
1987 73
1988 83
1989 86
1990 59
1991 70
1992 80
1993 66
1994 72
1995 56
1996 84
1997 84
1998 97
1999 91
2000 115
2001 78
2002 96
2003 98
2004 89
2005 92
2006 93
2007 104
2008 123
2009 119
2010 134
2011 184
2012 157
2013 154
2014 157
2015 149
2016 178
2017 183
2018 190
2019 198
2020 206
2021 233
2022 208
2023 222
2024 203

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,048 results

Results by year

Filters applied: . Clear all
Page 1
Association between vascular endothelial growth factor-mediated blood-brain barrier dysfunction and stress-induced depression.
Matsuno H, Tsuchimine S, O'Hashi K, Sakai K, Hattori K, Hidese S, Nakajima S, Chiba S, Yoshimura A, Fukuzato N, Kando M, Tatsumi M, Ogawa S, Ichinohe N, Kunugi H, Sohya K. Matsuno H, et al. Among authors: sakai k. Mol Psychiatry. 2022 Sep;27(9):3822-3832. doi: 10.1038/s41380-022-01618-3. Epub 2022 May 26. Mol Psychiatry. 2022. PMID: 35618888
Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary.
Tanizaki J, Yonemori K, Akiyoshi K, Minami H, Ueda H, Takiguchi Y, Miura Y, Segawa Y, Takahashi S, Iwamoto Y, Kidera Y, Fukuoka K, Ito A, Chiba Y, Sakai K, Nishio K, Nakagawa K, Hayashi H. Tanizaki J, et al. Among authors: sakai k. Ann Oncol. 2022 Feb;33(2):216-226. doi: 10.1016/j.annonc.2021.11.009. Epub 2021 Nov 26. Ann Oncol. 2022. PMID: 34843940 Free article. Clinical Trial.
The wound/burn guidelines - 6: Guidelines for the management of burns.
Yoshino Y, Ohtsuka M, Kawaguchi M, Sakai K, Hashimoto A, Hayashi M, Madokoro N, Asano Y, Abe M, Ishii T, Isei T, Ito T, Inoue Y, Imafuku S, Irisawa R, Ohtsuka M, Ogawa F, Kadono T, Kawakami T, Kukino R, Kono T, Kodera M, Takahara M, Tanioka M, Nakanishi T, Nakamura Y, Hasegawa M, Fujimoto M, Fujiwara H, Maekawa T, Matsuo K, Yamasaki O, Le Pavoux A, Tachibana T, Ihn H; Wound/Burn Guidelines Committee. Yoshino Y, et al. Among authors: sakai k. J Dermatol. 2016 Sep;43(9):989-1010. doi: 10.1111/1346-8138.13288. Epub 2016 Mar 12. J Dermatol. 2016. PMID: 26971391
Tumor Microenvironment Landscape of NSCLC Reveals Resistance Mechanisms for Programmed Death-Ligand 1 Blockade After Chemoradiotherapy: A Multicenter Prospective Biomarker Study (WJOG11518L:SUBMARINE).
Haratani K, Nakamura A, Mamesaya N, Mitsuoka S, Yoneshima Y, Saito R, Tanizaki J, Fujisaka Y, Hata A, Tsuruno K, Sakamoto T, Teraoka S, Oki M, Watanabe H, Sato Y, Nakano Y, Otani T, Sakai K, Tomida S, Chiba Y, Ito A, Nishio K, Yamamoto N, Nakagawa K, Hayashi H. Haratani K, et al. Among authors: sakai k. J Thorac Oncol. 2023 Oct;18(10):1334-1350. doi: 10.1016/j.jtho.2023.06.012. Epub 2023 Jun 25. J Thorac Oncol. 2023. PMID: 37364849 Free article.
Triggering Stent Optimization by Coronary Physiology.
Munhoz D, Sakai K, Collet C, Mizukami T. Munhoz D, et al. Among authors: sakai k. JACC Cardiovasc Interv. 2022 Nov 14;15(21):2228. doi: 10.1016/j.jcin.2022.09.010. JACC Cardiovasc Interv. 2022. PMID: 36357030 Free article. No abstract available.
5,048 results